Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(28.6%)

Phase 1

2(28.6%)

Phase 4

2(28.6%)

Phase 3

1(14.3%)

7Total

N/A(2)

Phase 1(2)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06904248Phase 3Completed

Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery

Role: lead

NCT06902090Phase 1Completed

Safety, Tolerability and Pharmacokinetics of Meloxicam Nanocrystal Injection in Healthy Subjects

Role: lead

NCT04912518Not ApplicableRecruiting

Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction

Role: collaborator

NCT06439368Phase 4Recruiting

Effect of Dezocine Combined With Sufentanil on the Quality of Postoperative Recovery and Analgesic Effect in Patients Undergoing Thoracic Surgery

Role: lead

NCT06381557Phase 4Not Yet Recruiting

Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules

Role: collaborator

NCT05976503Phase 1Completed

A Study of the Interaction of Tunodafil Hydrochloride Tablets and Alcohol

Role: lead

NCT04342455Not ApplicableUnknown

A Low-dose Radiation and Contrast Agent Exposure Protocol for Coronary CTA in Diabetic Patients

Role: collaborator

All 7 trials loaded